Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

New compounds from Japanese lab inhibit Th2-type cytokine production

April 7, 2000

No Comments

FDA gives go-ahead for Access to commence OraDisc clinical trials

April 5, 2000

No Comments

Chemokine receptor modulators in early development at AstraZeneca

April 5, 2000

No Comments

First phase II clinical trial of ABX-IL-8 begins in psoriasis

April 5, 2000

No Comments

Draxis seeks approval of Levulan PDT in Canada

March 31, 2000

No Comments

Organogenesis receives milestone payment related to Apligraf progress

March 30, 2000

No Comments

TRK-820 demonstrates kappa-receptor-mediated antipruritic effects in animal model

March 29, 2000

No Comments

SkyePharma and Bioglan establish marketing agreement for Solarase

March 23, 2000

No Comments

FDA approves modifications to Dermagraft IDE for diabetic foot ulcers

March 23, 2000

No Comments

Pharmadigm reports phase II results for DHEAS in burn patients

March 22, 2000

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Dermatologic
RSS

New compounds from Japanese lab inhibit Th2-type cytokine production

FDA gives go-ahead for Access to commence OraDisc clinical trials

Chemokine receptor modulators in early development at AstraZeneca

First phase II clinical trial of ABX-IL-8 begins in psoriasis

Draxis seeks approval of Levulan PDT in Canada

Organogenesis receives milestone payment related to Apligraf progress

TRK-820 demonstrates kappa-receptor-mediated antipruritic effects in animal model

SkyePharma and Bioglan establish marketing agreement for Solarase

FDA approves modifications to Dermagraft IDE for diabetic foot ulcers

Pharmadigm reports phase II results for DHEAS in burn patients

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

AI drives financings, approvals for APAC med-tech in 2024

Dermatologic RSS

Dermatologic
RSS